Published in Circ Res on July 01, 2010
Effect of Migalastat on Cardiac Involvement in Fabry Disease (MAIORA) | NCT03838237
Pervasive roles of microRNAs in cardiovascular biology. Nature (2011) 6.08
Atherosclerosis: current pathogenesis and therapeutic options. Nat Med (2011) 4.95
Haemolysis during sample preparation alters microRNA content of plasma. PLoS One (2011) 2.92
MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med (2014) 2.62
The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ (2013) 2.41
Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation (2011) 2.38
Regulation of vascular smooth muscle cell turnover by endothelial cell-secreted microRNA-126: role of shear stress. Circ Res (2013) 2.04
Intercellular transport of microRNAs. Arterioscler Thromb Vasc Biol (2013) 1.84
Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res (2012) 1.78
Myocardial AKT: the omnipresent nexus. Physiol Rev (2011) 1.76
Site-specific microRNA-92a regulation of Kruppel-like factors 4 and 2 in atherosusceptible endothelium. Arterioscler Thromb Vasc Biol (2012) 1.71
Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training. J Physiol (2011) 1.71
Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol (2013) 1.69
MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications. Diabetes (2011) 1.56
Emerging roles for platelets as immune and inflammatory cells. Blood (2014) 1.56
Plasma Levels of microRNA-145 Are Associated with Severity of Coronary Artery Disease. PLoS One (2015) 1.54
The Impact of Hemolysis on Cell-Free microRNA Biomarkers. Front Genet (2013) 1.54
Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays. J Clin Med (2015) 1.48
Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc Res (2011) 1.47
MiR-30-regulated autophagy mediates angiotensin II-induced myocardial hypertrophy. PLoS One (2013) 1.46
Extracellular/circulating microRNAs and their potential role in cardiovascular disease. Am J Cardiovasc Dis (2011) 1.43
miR-135a Suppresses Calcification in Senescent VSMCs by Regulating KLF4/STAT3 Pathway. Curr Vasc Pharmacol (2016) 1.42
Specific and sensitive quantitative RT-PCR of miRNAs with DNA primers. BMC Biotechnol (2011) 1.42
Identification and evaluation of plasma microRNAs for early detection of colorectal cancer. PLoS One (2013) 1.39
Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation. Arterioscler Thromb Vasc Biol (2011) 1.37
Cell-free Circulating miRNA Biomarkers in Cancer. J Cancer (2012) 1.37
Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. PLoS One (2012) 1.36
Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med (2014) 1.34
MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease. Immune Netw (2011) 1.29
MicroRNA therapeutics in cardiovascular medicine. EMBO Mol Med (2011) 1.28
Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection. J Transl Med (2012) 1.28
Cell-to-cell miRNA transfer: from body homeostasis to therapy. Pharmacol Ther (2012) 1.27
Circulating microRNAs as novel and sensitive biomarkers of acute myocardial Infarction. Clin Biochem (2012) 1.24
A translational study of urine miRNAs in acute myocardial infarction. J Mol Cell Cardiol (2012) 1.24
Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease. PLoS One (2013) 1.19
Tissue- and plasma-specific MicroRNA signatures for atherosclerotic abdominal aortic aneurysm. J Am Heart Assoc (2012) 1.18
Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus. PLoS One (2011) 1.18
Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol. Thromb J (2012) 1.17
Extracellular communication via microRNA: lipid particles have a new message. J Lipid Res (2013) 1.17
Endothelial microRNAs and atherosclerosis. Curr Atheroscler Rep (2013) 1.17
A novel real-time PCR assay of microRNAs using S-Poly(T), a specific oligo(dT) reverse transcription primer with excellent sensitivity and specificity. PLoS One (2012) 1.16
Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma. PLoS One (2011) 1.15
miR-125b regulates calcification of vascular smooth muscle cells. Am J Pathol (2011) 1.15
Polyphenols: benefits to the cardiovascular system in health and in aging. Nutrients (2013) 1.14
MicroRNA changes in human arterial endothelial cells with senescence: relation to apoptosis, eNOS and inflammation. Exp Gerontol (2011) 1.13
MicroRNAs in cardiac disease. Transl Res (2011) 1.13
The Role of MicroRNAs in Regulatory T Cells and in the Immune Response. Immune Netw (2011) 1.13
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis. J Transl Med (2013) 1.12
Rapid upregulation and clearance of distinct circulating microRNAs after prolonged aerobic exercise. J Appl Physiol (1985) (2014) 1.12
Differential expression of miR-145 in children with Kawasaki disease. PLoS One (2013) 1.12
MicroRNAs in vascular disease. J Cardiovasc Pharmacol (2011) 1.11
Roles of microRNA on cancer cell metabolism. J Transl Med (2012) 1.11
Functions of microRNAs in cardiovascular biology and disease. Annu Rev Physiol (2012) 1.10
MicroRNA Regulation of Atherosclerosis. Circ Res (2016) 1.10
Circulating miRNAs as potential marker for pulmonary hypertension. PLoS One (2013) 1.10
miR-200b is involved in intestinal fibrosis of Crohn's disease. Int J Mol Med (2012) 1.09
Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases. Cell Mol Neurobiol (2013) 1.09
Diagnostic potential of plasmatic MicroRNA signatures in stable and unstable angina. PLoS One (2013) 1.09
Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155/FOXO3a signaling pathway. Circ Res (2012) 1.09
Circulating miRNAs in cancer: from detection to therapy. J Hematol Oncol (2014) 1.08
Serum microRNA expression profile distinguishes enterovirus 71 and coxsackievirus 16 infections in patients with hand-foot-and-mouth disease. PLoS One (2011) 1.08
Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury. Cardiovasc Res (2012) 1.07
Massive analysis of cDNA Ends (MACE) and miRNA expression profiling identifies proatherogenic pathways in chronic kidney disease. Epigenetics (2013) 1.07
Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction. Circ Cardiovasc Genet (2011) 1.06
MicroRNA-145 restores contractile vascular smooth muscle phenotype and coronary collateral growth in the metabolic syndrome. Arterioscler Thromb Vasc Biol (2013) 1.06
MicroRNAs expression profiles in cardiovascular diseases. Biomed Res Int (2014) 1.06
A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction. Eur Heart J (2013) 1.06
MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart. Age (Dordr) (2012) 1.06
Predictors and prevention of diabetic cardiomyopathy. Diabetes Metab Syndr Obes (2013) 1.05
MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease. J Am Heart Assoc (2014) 1.05
Noncoding RNA in age-related cardiovascular diseases. J Mol Cell Cardiol (2015) 1.04
Toll-like receptors: new players in myocardial ischemia/reperfusion injury. Antioxid Redox Signal (2011) 1.04
Inorganic phosphate accelerates the migration of vascular smooth muscle cells: evidence for the involvement of miR-223. PLoS One (2012) 1.03
MicroRNA in cardiovascular calcification: focus on targets and extracellular vesicle delivery mechanisms. Circ Res (2013) 1.02
Assessment of RT-qPCR normalization strategies for accurate quantification of extracellular microRNAs in murine serum. PLoS One (2014) 1.02
MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism. J Transl Med (2011) 1.01
Microvesicles/exosomes as potential novel biomarkers of metabolic diseases. Diabetes Metab Syndr Obes (2012) 1.01
Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders. Blood Cancer J (2012) 1.01
Regulation of microRNA-155 in atherosclerotic inflammatory responses by targeting MAP3K10. PLoS One (2012) 1.01
The role of circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus. Int J Mol Sci (2014) 1.00
Oxidative stress activates endothelial innate immunity via sterol regulatory element binding protein 2 (SREBP2) transactivation of microRNA-92a. Circulation (2014) 1.00
Circulating microRNAs: a potential role in diagnosis and prognosis of acute myocardial infarction. Dis Markers (2013) 0.99
Diminished skeletal muscle microRNA expression with aging is associated with attenuated muscle plasticity and inhibition of IGF-1 signaling. FASEB J (2014) 0.98
miRNAs: roles and clinical applications in vascular disease. Expert Rev Mol Diagn (2011) 0.98
MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics. Int J Obes (Lond) (2015) 0.98
MicroRNAs in the onset and development of cardiovascular disease. Clin Sci (Lond) (2014) 0.98
Microglia change from a reactive to an age-like phenotype with the time in culture. Front Cell Neurosci (2014) 0.97
Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). PLoS One (2013) 0.97
Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular Diseases. Biomed Res Int (2015) 0.97
DiGeorge syndrome critical region 8 (DGCR8) protein-mediated microRNA biogenesis is essential for vascular smooth muscle cell development in mice. J Biol Chem (2012) 0.97
MicroRNAs -the next generation therapeutic targets in human diseases. Theranostics (2013) 0.97
Circulating MicroRNAs in cardiovascular disease. Circulation (2011) 0.96
MicroRNA-125b protects against myocardial ischaemia/reperfusion injury via targeting p53-mediated apoptotic signalling and TRAF6. Cardiovasc Res (2014) 0.96
Let-7 in cardiovascular diseases, heart development and cardiovascular differentiation from stem cells. Int J Mol Sci (2013) 0.96
Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease. Cardiovasc Diabetol (2014) 0.96
MicroRNA Expression Profile in CAD Patients and the Impact of ACEI/ARB. Cardiol Res Pract (2011) 0.96
Hypoxia-induced deregulation of miR-126 and its regulative effect on VEGF and MMP-9 expression. Int J Med Sci (2013) 0.96
MiRNAs as biomarkers of myocardial infarction: a meta-analysis. PLoS One (2014) 0.96
Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases. Sci Rep (2014) 0.95
Extracellular vesicles as therapeutic tools in cardiovascular diseases. Front Immunol (2014) 0.95
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
Universal definition of myocardial infarction. Circulation (2007) 11.69
Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med (2006) 11.66
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet (2004) 11.13
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
Endothelial progenitor cells: characterization and role in vascular biology. Circ Res (2004) 7.91
Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol Cell (2008) 7.68
Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med (2008) 7.25
Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med (2006) 6.77
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J (2007) 6.51
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation (2002) 6.50
Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med (2003) 6.09
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med (2008) 6.08
Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med (2014) 5.25
Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol (2012) 5.12
Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res (2007) 5.09
MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science (2009) 5.07
Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res (2008) 4.95
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial. Lancet (2010) 4.72
Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J (2006) 4.69
Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol (2005) 4.67
Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation (2005) 4.49
Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation (2003) 4.36
Targets and dynamics of promoter DNA methylation during early mouse development. Nat Genet (2010) 4.27
Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest (2005) 4.25
Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res (2012) 4.19
Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med (2013) 4.16
Soluble CD40 ligand in acute coronary syndromes. N Engl J Med (2003) 4.06
MicroRNA-34a regulates cardiac ageing and function. Nature (2013) 4.03
Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J (2007) 3.98
Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol (2004) 3.84
Endothelial function: cardiac events. Circulation (2005) 3.80
Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest (2005) 3.66
Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation (2002) 3.48
CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation (2002) 3.38
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J (2002) 3.36
SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev (2007) 3.34
Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation (2004) 3.26
Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol (2008) 3.15
Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood (2003) 2.93
Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood (2010) 2.80
Bivalirudin started during emergency transport for primary PCI. N Engl J Med (2013) 2.80
Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res (2012) 2.78
Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res (2007) 2.71
Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation (2003) 2.69
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens (2009) 2.68
Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation (2003) 2.63
CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res (2005) 2.62
Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation (2008) 2.62
Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res (2014) 2.60
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol (2007) 2.56
Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation (2003) 2.52
Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation (2004) 2.51
Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase. Nature (2011) 2.47
Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res (2005) 2.47
Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am Coll Cardiol (2007) 2.43
Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol (2007) 2.31
Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. J Am Coll Cardiol (2008) 2.31
Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol (2011) 2.31